PHILADELPHIA, June 15, 2017 /PRNewswire-USNewswire/ -- Today, The Pew Charitable Trusts announced 22 exceptional early-careerresearchers as Pew scholars in the biomedical sciences. Each scholar will receive four years of flexible funding to pursue foundational research.
"Pew is proud to support these investigators as they use novel approaches to illuminate the mechanisms
The 2017 scholars—all of whom hold assistant professor positions—join a thriving community of more than 900 biomedical scientists who have received awards from Pew since 1985. Each year, current scholars come together to discuss their research and learn from peers in fields outside of their own.
"Innovation is critical for scientists trying to crack some of the toughest questions in human health," said Craig C. Mello, Ph.D., a 1995 Pew scholar, 2006 Nobel laureate in physiology or medicine, and chair of the national advisory committee for the scholars program. "Pew's biomedical programs not only provide young scientists with the flexibility to pursue creative ideas; they also spark interdisciplinary thinking and collaborations that can open new paths in the search for answers."
The scholars are chosen from nominations made by some 180 leading academic and research institutions. This year's class includes scientists using cutting-edge techniques to study the factors controlling gene expression, the behavior of our brains' neurons, and communication among the various bacteria in our bodies. Better understanding of such fundamental processes will lay important groundwork for potential treatments of neurological disorders, kidney disease, and other illnesses.
Five members of the 2017 class of scholars will receive awards with support from the Kathryn W. Davis Peace by Pieces Fund. They were selected for their commitment to investigating health challenges in the brain as it ages.
The 2017 Pew scholars in the biomedical sciences are:
Mohamed S. Abou Donia, Ph.D.Princeton UniversityChemical Biology
José L. Avalos, Ph.D.Princeton UniversitySystems Biology
Eiman Azim, Ph.D.Salk Institute for Biological StudiesNeuroscience
Erhu Cao, Ph.D.University of UtahBiochemistry
Ibrahim Cissé, Ph.D.Massachusetts Institute of TechnologyBiophysics
Michael A. Crickmore, Ph.D.Boston Children's HospitalNeuroscience
Rachel J. Dutton, Ph.D.University of California, San DiegoMicrobiology
Michael M. Halassa, M.D., Ph.D.New York UniversityNeuroscience
Jorge Henao-Mejia, M.D., Ph.D.Children's Hospital of PhiladelphiaImmunology
Ya-Chieh Hsu, Ph.D.Harvard UniversityStem Cell Biology
Gene-Wei Li, Ph.D.Massachusetts Institute of TechnologyCell Biology
Anna Victoria R. Molofsky, M.D., Ph.D.University of California, San FranciscoNeuroscience
Shaeri Mukherjee, Ph.D.University of California, San FranciscoMicrobiology and Immunology
Alan C. Mullen, M.D., Ph.D.Massachusetts General HospitalCell Biology; Molecular Biology
Carolyn M. Phillips, Ph.D.University of Southern CaliforniaMolecular Biology
Kaoru Saijo, M.D., Ph.D.University of California, BerkeleyImmunology
Robert Spitale, Ph.D.University of California, IrvineChemical Biology
David Veesler, Ph.D.University of WashingtonVirology
Elizabeth Villa, Ph.D.University of California, San DiegoBiophysics
Bin Wu, Ph.D.Johns Hopkins UniversityBiophysics
Naoki Yamanaka, Ph.D.University of California, RiversideEndocrinology
Nilay Yapici, Ph.D.Cornell UniversityNeuroscience
Visit the program page to read the scholars' full abstracts and learn more about the program.
The 2017 classes of Pew-Stewart scholars for cancer research and Pew Latin American fellows were also announced today.
The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Learn more at www.pewtrusts.org.
Matt Mulkey, 202-862-9864, firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pew-awards-22-promising-biomedical-researchers-funding-to-advance-human-health-300474199.html
SOURCE The Pew Charitable Trusts
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All